Oncorus Inc is a preclinical-stage biopharmaceutical company focused on the intravenous administration of self-amplifying RNA to transform outcomes for cancer patients.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
2015
(há 9 anos)
2020
(4 years ago)
NASDAQ
Listagem
Andover
Sede • Massachusetts64
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ONCRSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.